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Abstract
Background: Positive neurotrophic effects of hyperbaric oxygen treatment may be more easily achieved by
applying a Perflourocarbon (PFC) emulsion gel to the repair site. PFCs are halogen substituted carbon oils with
unique oxygen transport potentials that are capable of increasing oxygen availability in local tissues. The purpose
of this study was to determine if the application of a PFC emulsion to a repaired nerve would improve recovery.
Materials and methods: The left tibial nerve of 21 immature female Sprague-Dawley rats was transected,
immediately repaired, and then circumferentially coated with PFC gel (Group A, n = 7), PFC-less gel (Group B, n =
7), or nothing (suture only, Group C, n = 7). At eight weeks post surgery, electrophysiological testing and
histological and morphological analysis was performed.
Results: No statistically significant differences between experimental groups were found for muscle size and
weight, axon counts, or nerve conduction velocity. Group A had a significantly smaller G-ratio than Groups B and C
(p < .0001).
Conclusion: Overall results do not indicate a functional benefit associated with application of a PFC emulsion gel
to rodent tibial nerve repairs. A positive effect on myelination was seen.
Keywords: Perfluorocarbons, Nerve Repair, Nerve Regeneration
Background
Despite significant advances in our understanding of
nerve regeneration over the past six decades, achieving
consistent satisfactory results following major nerve
repair or reconstruction remains a challenge. Enhance-
ment of the local biological environment towards a
more neurosupportive environment is a common strat-
egy aimed at improving nerve repair outcomes[1,2].
Strategies to increase tissue oxygenation at the repair
site have received some attention in the past, though
this has generally focused on hyperbaric oxygenation
(HBO). Hyperbaric oxygenation treatment to improve
nerve regeneration, involves emersion of the subject
(patient or animal) in a pressurized and enriched oxygen
environment for several hours at a time following the
nerve repair. Results of this approach are mixed, but
several reports suggest a positive effect[3-7].
Obvious problems with HBO include obtaining access
to the expensive pressurized oxygenation chamber, the
investment of prolonged unproductive periods of time
w i t h i nt h ec h a m b e r ,a n dt h ep o s s i b l yn e g a t i v ee f f e c t so f
fluctuating oxygen tensions associated with interval
treatment schedules (i.e. high oxygenation levels will
drop once the subject leaves the chamber). A less con-
strained approach for enhanced oxygen therapy may be
possible through the use of perfluorocarbons. Perfluoro-
carbons are highly non-polar, biologically inert oils (first
discovered during development of the atomic bomb),
which possess unique gas transport potential. Perfluoro-
carbons (PFC) exhibit oxygen solubilities a factor of
about 50× greater than that of water[8]. When applied
around a nerve repair, PFCs may be able to provide
local oxygen transport to damaged tissues without the
disadvantages associated with HBO. The purpose of this
study is to evaluate the effects of a PFC emulsion gel on
functional nerve regeneration.
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The perfluorocarbon gel used was prepared using a pro-
prietary PFC similar in properties and oxygen solubility
to perfluorodecalin. The gel was prepared in a manner
s i m i l a rt ot h a td e s c r i b eb yM o o r e [ 9 ] .T h ei s o l a t e dg e l
contained about 87 wt% of the PFC and was heat steri-
lized at 122°C for 2 hours before use.
Twenty-one immature (3 month old) Sprague-Dawley
rats were used for study after obtaining necessary
approval from our institution’s animal review board in
accordance with national guidelines. All animals were
housed in a temperature and humidity controlled envir-
onment with 12:12 day-night cycle and were provided
food and water ad libitum. The rats were divided into
three groups (N = 7), A (repair with application of PFC
emulsion gel), B (repair with application of PFC-less gel
carrier only), and C (repair only). For all procedures,
anesthesia was induced with 5% isoflurane in a closed
chamber and maintained using 2-3% isoflurane via nose
cone inhalation. Surgical manipulations of the left hind
limb nerves were performed under sterile conditions.
The sciatic, tibial, and peroneal nerves were exposed
through a standard biceps femoris-semitendinosis mus-
cle splitting approach. The tibial nerve was isolated and
transected one centimeter distal to the bifurcation from
the sciatic nerve. Under operating microscope magnifi-
cation, the cut ends of the tibial nerve were immediately
co-apted with two 10-0 nylon epineural sutures placed
180 degrees apart. The repair site for groups A and B
were circumferentially coated with PFC emulsion gel
(Group A) or gel carrier only (Group B). The wounds
were closed with 4-0 nonabsorbent monofilament and
the animals allowed to recover from anesthesia before
being returned to their cages. Post-operative analgesia
was consistently accomplished with subcutaneous
administration of buprenorphine 0.5 mg/kg and aceta-
minophen 272 mg/100 cc added to the drinking water.
Final testing took place 8 weeks after the initial sur-
gery. After the induction of general anesthesia, both the
right and left sciatic nerves were exposed to allow test-
ing on both the experimental and control hind limbs
extremities. The sciatic nerve was isolated at the sciatic
notch and proximal branches of the sciatic nerve trans-
ected to reduce muscle contraction and reduce interfer-
ence. Two bipolar electrodes were placed on the
isolated nerve with the stimulating electrode positioned
at the proximal sciatic nerve and the recording bipolar
electrode placed under the tibial nerve distally (with the
interval space recorded for nerve conduction velocity
calculation). Single square pulses of 0.02 msec duration
were applied while gradually increasing the strength of
the stimulus until a maximum compound action poten-
tial waveform was achieved. This maximum stimulus
was applied three times to each nerve and latency, base
to peak amplitude, and peak to peak amplitude mea-
sured and recorded using a PowerLab data acquisition
system (ADInstruments, Inc., Colorado Springs, CO)
and an Apple iBook laptop computer (Cupertino,
California).
Once nerve testing was complete, the tibial nerves and
gastrocnemius muscles were harvested and fixed in 10%
formalin solution. Nerve sections were obtained 5 mm
proximal and 5 mm distal to the repair site and stained
with toludine blue for histological analysis (Figure 1).
Analysis consisted of averaged axon counts per 5 ran-
dom high power fields (40× magnification) and G-ratio
assessments using the same high power fields. Axon
counts were performed manually using ImageJ 1.42 soft-
ware (NIH website) and bias avoided by using the same
five areas in each specimen. G-ratios were calculated by
measuring the diameter of axons and dividing by the
total diameter of that axon plus the surrounding myelin
sheath. The gastrocnemius muscles were harvested from
both hind limbs for diameter and weight measurements.
The animals were euthanized with an intraperitoneal
overdose of Euthasol (150 mg/kg).
Statistical analysis was performed using the ANOVA
and Tukey’s post test analysis, comparing the individual
experimental groups versus all control groups, as well as
the experimental groups to each other.
Power analysis
Power analysis sample size determination was based on
standard deviations and reported differences noted in
similar studies and using GraphPad StatMate software
(GraphPad Software, Inc., San Diego, CA). The study by
Eguiluz-Ordonez et al. used a similar rodent sciatic
nerve model but looked at the effect of post repair
Figure 1 Microscopic images in 40× magnification of (a)
control nerve, (b) PFC gel to repair, (c) carrier only to repair
and (d) repair only nerve 5 mm distal to repair site.
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difference in motor latency (mean difference .46 ms,
average Standard Deviation 0.34) with 10 rats in each
group[6]. To achieve 90% power, seven rats in each
group would demonstrate this difference if a similar
standard deviation is expected.
Results
Muscle Weight and Diameter
For all experimental limbs, the gastrocnemius muscle
measurements demonstrated statistically significant
lighter weights and smaller diameters (p < 0.0001) when
compared with control limbs. The average weight and
diameter of the experimentally manipulated muscles
were 59% and 73% of the control side, respectively.
There was no statistically significant difference in mus-
cle size or weight between the three experimental
groups (Table 1).
Axon Count
There was no statistically significant difference in axon
counts (p = 0.09) per averaged high power field between
the experimental and control groups, nor within the
experimental groups (Table 1).
Nerve Conduction Velocity
There was a significant increase in tibial nerve motor
latency (p < 0.05), a decrease in tibial nerve amplitude
(p < 0.0001) in all three experimental groups compared
to the control nerves but no differences between the
experimental groups (Table 1).
Histomorphometry
There was a significantly increased G-ratio in the
experimental groups compared to the control groups (p
< 0.05). Among the experimental groups, Group A
(PFC) had a significantly smaller G-ratio than Groups B
and C (p < 0.0001) (Table 1).
Discussion
Perfluorocarbons are unique compounds created when
hydrocarbon chains undergo a hydrogen substitution
with fluorine molecules. The subsequent oils are stable,
inert, and have low surface tensions. Because they are
highly non-polar and extremely hydrophobic, they will
not bind to proteins and are usually lipophilic. Used in
a variety of industrial and medical applications, PFCs
possess impressively high oxygen (and other gas) solubi-
lity potentials which has spurred interest in a potential
role as a “blood substitute”. Oxygen molecules do not
b i n dt ot h ep e r f l u o r c a r b o nm o l e c u l e s( l i k et h e yd ot o
hemoglobin), but rather are trapped in between the
molecules. This dissolved oxygen can be made available
to surrounding tissues in certain circumstances [8].
When applied directly to a tissue bed, PFC gel has also
been shown to improve wound healing[10]. We have
hypothesized that application of a PFC emulsion gel
around a repaired nerve might be expected to increase
oxygen availability at the repair site and subsequently
result in improved nerve regeneration.
Possible beneficial mechanisms of improved oxygena-
tion on nerve regeneration include promotion of survi-
val of marginal tissue, reduced edema and improved
microcirculation, and up-regulation of growth factors
[11]. Additionally, low oxygen tension has been corre-
lated with scar tissue formation[12,13]. Scar tissue can
block regenerating axons acutely or, more chronically,
can cause secondary compression resulting in “strangu-
lation” of the nerve and traction neuritis. Both can inhi-
bit nerve function and may contribute to chronic
neuropathic pain.
Increased oxygen tissue saturation as seen with HBO
treatment has demonstrated potential benefits for nerve
regeneration in both experimental and clinical settings.
Zamboni et al. demonstrated improved functional recov-
ery (walking track analysis) and decreased perineural
scarring in rats treated with hyperbaric oxygen (HBO)
Table 1 Results of testing for all three experimental groups and control limbs
Exp -A (PFC) Exp -B (Gel) Exp -C (repair only) Control
mean SD mean SD mean SD mean SD
Axon Count 175.0 37.66 184.9 16.56 189.3 31.66 189.7 28.45
Muscle Diameter (mm) 6.19 1.06 6.82 0.38 7.76 1.09 9.45 0.54
G-ratio 0.6136* 0.1322 0.6863 0.0808 0.6858 0.0974 0.6465** 0.0749
Muscle Weight (g) 1.119 0.1299 1.152 0.1002 1.241 0.1070 1.998** 0.2112
Motor Latency (msec) (N to N) 2.459 0.3596 2.671 0.3974 2.477 0.3406 1.944** 0.3942
Motor Latency (msec) (N-M) 3.030 0.4727 3.094 0.9046 2.646 0.6688 2.362** 0.3689
Amplitude (μV)
Base to Peak
1833 1292 2788 3028 2675 1255 5983** 3908
Amplitude (μV)
Peak to Peak
3084 2031 3611 3287 4070 2211 8980** 6465
* statistically significant difference to Exp-B and Exp-C
** statistically significant to all Exp (A, B, C) groups
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injury (with nerves “stripped” of extrinsic blood supply)
[3]. Using electron and light microscopy, Bradshaw et al.
found more complete recovery of crushed rabbit sciatic
nerves following HBO treatment[4]. Likewise, Haapa-
niemi et al. demonstrated improved axonal regeneration
into nerve grafts when experimental rats received HBO
treatment immediately following repair[5]. Eguiluz et al.,
while unable to demonstrate histological improvement
with HBO treatment, noted improved functional and
electrophysiological recovery in a rat sciatic nerve injury
[6]. From a clinical perspective, Zhao reported on the
beneficial effects of HBO combined with prompt surgi-
cal repair of nerve injuries[7].
Similar benefits as seen with HBO treatment were not
demonstrated in our study. Morphological and electro-
physiological data did not demonstrate any significant
positive or negative effect when compared to either the
carrier gel group or to the repair only group. A lower
G-ratio, however, indicating a higher myelin to axon
diameter ratio, was found in the PFC group. Similar
positive effects on myelination have been seen with
HBO[4,14]. Though this may represent faster axon
regeneration and maturation (as has also been asso-
ciated with HBO treatment in other rodent nerve repair
models [5,15]), our study design did not specifically
evaluate this variable and the exact significance or etiol-
ogy of this finding is not known. Our evaluation period
of only 8 weeks after nerve repair, however, was chosen
specifically to identify this type of subtle difference in
nerve regeneration between groups as longer recovery
periods in similar rodent models have been recently
associated with a “blow though effect”– eventually
resulting in robust axonal regeneration regardless of
treatment variables[16].
Our failure to demonstrate definite neurotrophic ben-
efits with the PFC emulsion gel, however, has several
possible explanations. First, although oxygen delivery to
the nerve should have improved theoretically with PFC
application, this was unable to be verified and without
this effect, the emulsion gel would have no beneficial
properties. Though this seems like a grave oversight in
the study design, it must be pointed out that accurate
measurements of oxygen tension at an in vivo nerve
repair site (such as in this model) would be impossible.
Furthermore, none of the already referenced studies
regarding the effects of HBO on nerve healing and
regeneration confirmed increased perineural or neural
oxygen tension. Second, oxygenation (or perfusion) of
the neural tissue may not have been an issue with this
straightforward repair model[17] and the potential bene-
fits of improving oxygenation may only be seen with
ischemic tissue. A “rescue effect” has been demonstrated
in experimental ischemic nerve tissue treated with HBO
[18]. Other studies, however, fail to support this expla-
nation. No functional or histological effect was seen
with HBO treatment in an entubulated, acellular, or
“hypoxic” rodent nerve repair model[15,19-21].
The final possible explanation for the lack of neuro-
trophic benefit seen in our study is that the results of
previous HBO studies are overstated and that increased
oxygenation at the nerve repair site may have no effect
or may even be potentially harmful. In contrast to the
supportive studies already cited, other studies have failed
to demonstrate any benefit of HBO on nerve regenera-
tion[19,22,23]. Potential counter productive effects of
HBO could include decreased inflammatory cell
responses[24] (which might affect macrophages neces-
sary to clear debris from the endoneural tubes which is
essential for axon regneration), though no specific
macrophage effect has been demonstrated with HBO
[21], and we did not evaluate macrophages in our study.
Additionally, HBO has been demonstrated to increase
nitrous oxide (NO) production[25]. Nitrous oxide may
actually inhibit nerve regeneration and even be neuro-
toxic[26-28].
The above theories and apparently contradictory
experimental study results may not be in complete con-
flict. It is likely that the situation is more complicated
than presented and that there may be a “sweet spot” for
oxygen levels. Too little or too much oxygen may both
be detrimental to nerve regeneration. In this study, PFC
emulsion gel when applied directly to a primary rodent
tibial nerve repair increased myelination of regenerating
axons but did not demonstrate any net positive neuro-
trophic effect. Further study to confirm local tissue
effects of PFC gel application as well as a dose response
curve would be appropriate before any final conclusions
are made.
Conclusion
Although increased axonal myelination was noted, this
was not associated with functional benefit following the
application of a PFC emulsion gel to a tibial nerve repair
in a rodent model.
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